{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T15:54:33Z","timestamp":1769356473210,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013170","name":"Ono Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.yjmcc.2010.04.006","type":"journal-article","created":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T04:48:58Z","timestamp":1271652538000},"page":"176-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Prostacyclin receptor suppresses cardiac fibrosis: Role of CREB phosphorylation"],"prefix":"10.1016","volume":"49","author":[{"given":"Elsa C.","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Dusting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitesh M.","family":"Peshavariya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline J.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodney","family":"Dilley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuh","family":"Narumiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2010.04.006_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1524-6175.2007.06626.x","article-title":"Mechanisms of cardiac fibrosis in hypertension","volume":"9","author":"Diez","year":"2007","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"Suppl 1","key":"10.1016\/j.yjmcc.2010.04.006_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000177160","article-title":"Ventricular remodeling","volume":"87","author":"Maisch","year":"1996","journal-title":"Cardiology"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib3","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0008-6363(98)00305-8","article-title":"Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors","volume":"41","author":"Nicoletti","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2174\/1568010033484098","article-title":"Inflammatory mechanisms in myocardial infarction","volume":"2","author":"Ren","year":"2003","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","article-title":"The role of TGF-beta signaling in myocardial infarction and cardiac remodeling","volume":"74","author":"Bujak","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1159\/000109148","article-title":"Involvement of NADPH oxidases in cardiac remodelling and heart failure","volume":"27","author":"Sirker","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1570161052773951","article-title":"Transforming growth factor-beta, cell signaling and cardiovascular disorders","volume":"3","author":"Agrotis","year":"2005","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib8","doi-asserted-by":"crossref","first-page":"27161","DOI":"10.1074\/jbc.274.38.27161","article-title":"Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression","volume":"274","author":"Hanafusa","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib9","doi-asserted-by":"crossref","first-page":"22368","DOI":"10.1074\/jbc.271.37.22368","article-title":"Altered transforming growth factor signaling in epithelial cells when ras activation is blocked","volume":"271","author":"Hartsough","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/01.sla.0000189606.58343.cd","article-title":"Transforming growth factor-beta promotes pro-fibrotic behavior by serosal fibroblasts via PKC and ERK1\/2 mitogen activated protein kinase cell signaling","volume":"242","author":"Mulsow","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1523-1747.2002.01719.x","article-title":"Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts","volume":"118","author":"Sato","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib12","doi-asserted-by":"crossref","first-page":"39237","DOI":"10.1074\/jbc.M003339200","article-title":"Synergistic cooperation between Sp1 and Smad3\/Smad4 mediates transforming growth factor beta1 stimulation of alpha 2(I)-collagen (COL1A2) transcription","volume":"275","author":"Zhang","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib13","first-page":"625","article-title":"Multiple signalling options for prostacyclin","volume":"24","author":"Wise","year":"2003","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cmet.2005.08.005","article-title":"Prostacyclin protects against elevated blood pressure and cardiac fibrosis","volume":"2","author":"Francois","year":"2005","journal-title":"Cell Metab"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/CIRCULATIONAHA.104.527077","article-title":"Augmented cardiac hypertrophy in response to pressure overload in mice lacking the prostaglandin I2 receptor","volume":"112","author":"Hara","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.HYP.30.5.1047","article-title":"Prostacyclin release by rat cardiac fibroblasts: inhibition of collagen expression","volume":"30","author":"Yu","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib17","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1096\/fj.02-0204fje","article-title":"Prostacyclin derivatives prevent the fibrotic response to TGF-beta by inhibiting the Ras\/MEK\/ERK pathway","volume":"16","author":"Stratton","year":"2002","journal-title":"Faseb J"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/HYPERTENSIONAHA.107.101980","article-title":"Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction","volume":"51","author":"Looi","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib19","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.bjp.0707449","article-title":"Failure of antioxidants to protect against angiotensin II-induced aortic rupture in aged apolipoprotein(E)-deficient mice","volume":"152","author":"Jiang","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1210\/en.2007-1220","article-title":"Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis","volume":"149","author":"Xu","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib21","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1089\/ars.2009.2579","article-title":"Translation-linked mRNA destabilization accompanying serum-induced Nox4 expression in human endothelial cells","volume":"11","author":"Peshavariya","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib22","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1161\/ATVBAHA.107.149450","article-title":"Important role of Nox4 type NADPH oxidase in angiogenic responses in human microvascular endothelial cells in vitro","volume":"27","author":"Datla","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib23","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/emboj\/17.11.3091","article-title":"Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene","volume":"17","author":"Dennler","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib24","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1006\/jmcc.1997.0435","article-title":"Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts","volume":"29","author":"Campbell","year":"1997","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib25","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/01.RES.0000150369.68826.2f","article-title":"Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II","volume":"95","author":"Chen","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib26","doi-asserted-by":"crossref","first-page":"H3020","DOI":"10.1152\/ajpheart.2000.279.6.H3020","article-title":"Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro","volume":"279","author":"Hao","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib27","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1210\/en.2008-0165","article-title":"Transforming growth factor-beta blockade down-regulates the renin-angiotensin system and modifies cardiac remodeling after myocardial infarction","volume":"149","author":"Ellmers","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib28","doi-asserted-by":"crossref","first-page":"14828","DOI":"10.1016\/S0021-9258(17)36699-1","article-title":"Transforming growth factor-beta stimulates alpha 2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site","volume":"269","author":"Inagaki","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib29","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1124\/mol.106.028951","article-title":"cAMP inhibits transforming growth factor-beta-stimulated collagen synthesis via inhibition of extracellular signal-regulated kinase 1\/2 and Smad signaling in cardiac fibroblasts","volume":"70","author":"Liu","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib30","doi-asserted-by":"crossref","first-page":"7623","DOI":"10.1016\/S0021-9258(17)37333-7","article-title":"Recombinant cyclic AMP response element binding protein (CREB) phosphorylated on Ser-133 is transcriptionally active upon its introduction into fibroblast nuclei","volume":"269","author":"Alberts","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0008-6363(00)00037-7","article-title":"Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart","volume":"46","author":"Kupfahl","year":"2000","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib32","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cardiores.2006.07.012","article-title":"TGFbeta, cardiac fibroblasts, and the fibrotic response","volume":"74","author":"Leask","year":"2007","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib33","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/01.HYP.36.5.747","article-title":"Reduction in left ventricular messenger RNA for transforming growth factor beta(1) attenuates left ventricular fibrosis and improves survival without lowering blood pressure in the hypertensive TGR(mRen2)27 Rat","volume":"36","author":"Pinto","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib34","doi-asserted-by":"crossref","first-page":"H107","DOI":"10.1152\/ajpheart.00763.2003","article-title":"Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes","volume":"287","author":"Sarkar","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00395-007-0689-5","article-title":"Transforming growth factor-beta receptor antagonism attenuates myocardial fibrosis in mice with cardiac-restricted overexpression of tumor necrosis factor","volume":"103","author":"Sakata","year":"2008","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.yjmcc.2010.04.006_bib36","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00395-008-0739-7","article-title":"Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction","volume":"103","author":"Frantz","year":"2008","journal-title":"Basic Res Cardiol"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282810001458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282810001458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:18:46Z","timestamp":1758313126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282810001458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0022282810001458"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2010.04.006","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostacyclin receptor suppresses cardiac fibrosis: Role of CREB phosphorylation","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2010.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}